According to ONCOMINE analysis, there was no significant difference in mRNA expression of S100A1/A3/A5/A7/A7A/A8/A9/A12/B/G/Z between patients with PAAD and normal controls. The gene discussed is S100A1; the disease is pancreatic adenocarcinoma.